Contemporary Treatment of Amyloid Heart Disease

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10294745" target="_blank" >RIV/00216208:11110/15:10294745 - isvavai.cz</a>

Alternative codes found

RIV/00159816:_____/15:00061552 RIV/00064165:_____/15:10294745

Result on the web

<a href="http://www.ingentaconnect.com/content/ben/cpd/2015/00000021/00000004/art00010" target="_blank" >http://www.ingentaconnect.com/content/ben/cpd/2015/00000021/00000004/art00010</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Contemporary Treatment of Amyloid Heart Disease

Original language description

The amyloidoses represent a group of diseases characterized by extracellular deposition of abnormal protein, amyloid, which is formed by insoluble extracellular fibrils in beta-pleated sheets. Although cardiac involvement may occur in all types of amyloidoses, clinically relevant amyloid cardiomyopathy is a typical feature of AL amyloidosis and transthyretin-related amyloidoses. Congestive heart failure represents the commonest manifestation of amyloid heart disease. Noninvasive imaging techniques, especially echocardiography and cardiac magnetic resonance, play a major role in the diagnosis of amyloid cardiomyopathy; however, histological confirmation and exact typing of amyloid deposits is necessary whether in extracardiac location or directly in themyocardium. Early diagnosis of amyloid heart disease is of utmost importance as the presence and especially the severity of cardiac involvement generally drives the prognosis of affected subjects and plays a major role in determining the

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

<a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Current Pharmaceutical Design

ISSN

1381-6128

e-ISSN

—

Volume of the periodical

21

Issue of the periodical within the volume

4

Country of publishing house

AE - UNITED ARAB EMIRATES

Number of pages

16

Pages from-to

491-506

UT code for WoS article

000349458700009

EID of the result in the Scopus database

2-s2.0-84925840965